Home > Press > I-Flow Donates Infection-Fighting Wound Care Product to Help Earthquake Victims in China
Abstract:
Company's Subsidiary, AcryMed, Responds to Plea from Chinese Partner; Ships Cases of SilvaSorb® Antimicrobial Gel to Quake Site With Help from Local FedEx
I-Flow Corporation (NASDAQ:IFLO), through its wholly-owned subsidiary AcryMed, announced today it has donated 1,000 tubes of its SilvaSorb antimicrobial gel product to the Red Cross of China for distribution to earthquake victims in Sichuan, China. The company offered its help last week by donating the available product and arranged for immediate shipping to China after a plea from its Chinese partner.
According to reports out of China, the recent earthquake has left thousands injured and created unclean conditions, raising fear of the spread of dangerous infections. AcryMed's SilvaSorb is a unique topical gel containing a highly effective silver antimicrobial compound that kills bacteria and fungus commonly associated with wounds and burns. Those who use it may significantly reduce the risk of contracting a life-threatening infection.
"Stemming the tide of infections will be critical to saving lives," said AcryMed's chief technology officer and founder, Bruce Gibbins, a microbiologist. "SilvaSorb is a gel that requires no training to apply and the antimicrobial technology it contains can have a significant impact on reducing life-threatening infections contracted by the wounded. We were glad to be able to assist the relief efforts."
Gibbins further commented, "Three years ago we were also able to assist Medical Teams International in helping the Tsunami victims in South Asia. As a company that is committed to helping those who really need it, we are proud to be able to contribute what we can."
SilvaSorb was recently cleared by the FDA for over the counter distribution and is available as a CVS brand anti-microbial silver gel in CVS/pharmacy stores throughout the United States. SilvaSorb is also distributed to medical professionals in the U.S. by Medline Industries.
####
About I-Flow Corporation
I-Flow Corporation (www.IFLO.com) is improving surgical outcomes by designing, developing and marketing technically-advanced, low-cost drug delivery systems and innovative surgical products for post-surgical pain relief and surgical site care.
AcryMed is a pioneering leader at the forefront of innovations in the fields of infection control and wound healing. The company’s SilvaSorb® products for advanced wound care and SilvaGard® nanoparticle surface treatment for medical devices are among the breakthrough technologies that have distinguished AcryMed as an industry leader. A wholly-owned subsidiary of I-Flow Corporation, AcryMed maintains on-site GMP/ISO certified manufacturing and lab facilities at its Beaverton, Oregon headquarters. For more information on AcryMed visit www.AcryMed.com.
For more information, please click here
Contacts:
I-Flow Corporation
Orlando Rodrigues
Vice President, Marketing
949-206-2619
or
Brenner Associates Public Relations
AcryMed
Brad Brenner
503-736-0610
Copyright © Business Wire 2008
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Human Interest/Art
Drawing data in nanometer scale September 30th, 2022
Scientists prepare for the world’s smallest race: Nanocar Race II March 18th, 2022
Graphene nanotubes revolutionize touch screen use for prosthetic hands August 3rd, 2021
JEOL Announces 2020 Microscopy Image Grand Prize Winners January 7th, 2021
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||